Vyome Holdings HIND
NASDAQ HIND
$1.87 +0.03 (+1.63%)
As of: Oct 21, 2026 · 12:04 PM EDT

Vyome Holdings (HIND) Restructuring Costs (2024 - 2025)

Updated

Vyome Holdings' Restructuring Costs was $711,000 in Q2 2025, up 233.8% from $213,000 a year earlier and up 77.8% from the prior quarter.

Analysis

Vyome Holdings (HIND) Restructuring Costs (2024 - 2025) Analysis & Trends

For FY2024, Restructuring Costs at Vyome Holdings came in at $1.02 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn
10 Vyome Holdings 13.12 Mn -14.25 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 711,000.00
Mar 31, 2025 400,000.00
Jun 30, 2024 213,000.00
API Access

Vyome Holdings Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=HIND&period=max&api_key=YOUR_API_KEY